1. Home
  2. OCSL vs PBMWW Comparison

OCSL vs PBMWW Comparison

Compare OCSL & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • PBMWW
  • Stock Information
  • Founded
  • OCSL 2007
  • PBMWW N/A
  • Country
  • OCSL United States
  • PBMWW Canada
  • Employees
  • OCSL N/A
  • PBMWW 10
  • Industry
  • OCSL Finance: Consumer Services
  • PBMWW
  • Sector
  • OCSL Finance
  • PBMWW
  • Exchange
  • OCSL Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • OCSL N/A
  • PBMWW N/A
  • IPO Year
  • OCSL 2008
  • PBMWW N/A
  • Fundamental
  • Price
  • OCSL $16.07
  • PBMWW $0.02
  • Analyst Decision
  • OCSL Buy
  • PBMWW
  • Analyst Count
  • OCSL 7
  • PBMWW 0
  • Target Price
  • OCSL $18.17
  • PBMWW N/A
  • AVG Volume (30 Days)
  • OCSL 514.8K
  • PBMWW N/A
  • Earning Date
  • OCSL 11-19-2024
  • PBMWW N/A
  • Dividend Yield
  • OCSL 13.69%
  • PBMWW N/A
  • EPS Growth
  • OCSL N/A
  • PBMWW N/A
  • EPS
  • OCSL 0.85
  • PBMWW N/A
  • Revenue
  • OCSL $388,874,000.00
  • PBMWW N/A
  • Revenue This Year
  • OCSL $3.72
  • PBMWW N/A
  • Revenue Next Year
  • OCSL $1.22
  • PBMWW N/A
  • P/E Ratio
  • OCSL $19.00
  • PBMWW N/A
  • Revenue Growth
  • OCSL 11.90
  • PBMWW N/A
  • 52 Week Low
  • OCSL $15.55
  • PBMWW N/A
  • 52 Week High
  • OCSL $21.64
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 46.66
  • PBMWW N/A
  • Support Level
  • OCSL $15.55
  • PBMWW N/A
  • Resistance Level
  • OCSL $16.45
  • PBMWW N/A
  • Average True Range (ATR)
  • OCSL 0.27
  • PBMWW 0.00
  • MACD
  • OCSL -0.03
  • PBMWW 0.00
  • Stochastic Oscillator
  • OCSL 50.98
  • PBMWW 0.00

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: